Pesquisas alternativas:
liver thle2 » liver three (Expandir a Pesquisa)
doses liver » does liver (Expandir a Pesquisa), dose liver (Expandir a Pesquisa), doses over (Expandir a Pesquisa)
drugs does » drugs do (Expandir a Pesquisa)
drug doses » drug disease (Expandir a Pesquisa)
does deep » does sleep (Expandir a Pesquisa)
deep ther » deep tier (Expandir a Pesquisa), deep than (Expandir a Pesquisa), deep tcr (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
live ther » live them (Expandir a Pesquisa), live rather (Expandir a Pesquisa), liver other (Expandir a Pesquisa)
liver thle2 » liver three (Expandir a Pesquisa)
doses liver » does liver (Expandir a Pesquisa), dose liver (Expandir a Pesquisa), doses over (Expandir a Pesquisa)
drugs does » drugs do (Expandir a Pesquisa)
drug doses » drug disease (Expandir a Pesquisa)
does deep » does sleep (Expandir a Pesquisa)
deep ther » deep tier (Expandir a Pesquisa), deep than (Expandir a Pesquisa), deep tcr (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
live ther » live them (Expandir a Pesquisa), live rather (Expandir a Pesquisa), liver other (Expandir a Pesquisa)
1
Por Darkovska-Serafimovska, Marija, Janevik-Ivanovska, Emilija, Djorgoski, Icko, Arsova-Sarafinovska, Zorica, Zdravkovska, Milka, Balkanov, Trajan, Ugresic, Nenad
Publicado no Drug Des Devel Ther (2016)
“... aggregation of human platelets in a dose- and concentration-dependent manner (10 nM to 2 μM), but only...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Wang, Ying, Sun, Sheng-Gang, Zhu, Sui-Qiang, Liu, Chun-Feng, Liu, Yi-Ming, Di, Qing, Shang, Hui-Fang, Ren, Yan, Xiang, Wei, Chen, Sheng-Di
Publicado no Drug Des Devel Ther (2016)
“... for Parkinson’s disease (PD). A critical dose level above which a better benefit-to-harm ratio exists has not been...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
“..., BMI, drug dose and time from drug intake were recorded. RESULTS: All patients had a measurable...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
“..., resulting in a drug-antibody ratio of 2. In biodistribution studies, SIP(F8)-SS-DM1 accumulated in the tumor...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Kosilov, Kirill Vladimirovich, Loparev, Sergey, Kuzina, Irina, Shakirova, Olga, Zhuravskaya, Nataliya, Lobodenko, Alexandra
Publicado no Ther Adv Urol (2016)
“... in antimuscarinic (AM) drug treatment. BACKGROUND: The prevalence of urge urinary incontinence (UUI) is an average...”Publicado no Ther Adv Urol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Porteiro, Begoña, Fondevila, Marcos F., Buque, Xabier, Gonzalez-Rellan, Maria J., Fernandez, Uxia, Mora, Alfonso, Beiroa, Daniel, Senra, Ana, Gallego, Rosalia, Fernø, Johan, López, Miguel, Sabio, Guadalupe, Dieguez, Carlos, Aspichueta, Patricia, Nogueiras, Rubén
Publicado no Mol Metab (2017)
“... in the liver and in two human hepatic cells lines (HepG2 and THLE2). RESULTS: The attenuation of liver damage...”Publicado no Mol Metab (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Begoña Porteiro, Marcos F. Fondevila, Xabier Buque, Maria J. Gonzalez-Rellan, Uxia Fernandez, Alfonso Mora, Daniel Beiroa, Ana Senra, Rosalia Gallego, Johan Fernø, Miguel López, Guadalupe Sabio, Carlos Dieguez, Patricia Aspichueta, Rubén Nogueiras
Publicado em 2018-02-01
“... in the liver and in two human hepatic cells lines (HepG2 and THLE2). Results: The attenuation of liver damage...”Publicado em 2018-02-01
Obter o texto integral
Artigo
8
“... given for missing drugs were 9(27.3%) running out of medication/drug, 7(21.2%) being away from home...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Djobet, M. P. Ngogang, Singhe, David, Lohoue, Julienne, Kuaban, Christopher, Ngogang, Jeanne, Tambo, Ernest
Publicado no AIDS Res Ther (2017)
“.... ARVs drugs samples included Nevirapine, Efavirenz, and fixed dose combinations of Zidovudine...”Publicado no AIDS Res Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Vornov, James J., Wozniak, Krystyna M., Wu, Ying, Rojas, Camilo, Rais, Rana, Slusher, Barbara S.
Publicado em 2013
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Goláň, Lubor, Goker-Alpan, Ozlem, Holida, Myrl, Kantola, Ikka, Klopotowski, Mariusz, Kuusisto, Johanna, Linhart, Aleš, Musial, Jacek, Nicholls, Kathleen, Gonzalez-Rodriguez, Derlis, Sharma, Reena, Vujkovac, Bojan, Chang, Peter, Wijatyk, Anna
Publicado no Drug Des Devel Ther (2015)
“...PURPOSE: Efficacy and safety of agalsidase alfa at 0.2 mg/kg weekly were compared with 0.2 mg/kg...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
“... for therapeutic drug monitoring in clinical settings for Korean adult patients receiving living donor liver...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Yovich, John L, Alsbjerg, Birgit, Conceicao, Jason L, Hinchliffe, Peter M, Keane, Kevin N
Publicado no Drug Des Devel Ther (2016)
“... the protocols. The live birth productivity rates exceeded 50% for women <35 years and was 33.2% for the group...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Nygaard, Haakon B, Wagner, Allison F, Bowen, Garrett S, Good, Susan P, MacAvoy, Martha G, Strittmatter, Kurt A, Kaufman, Adam C, Rosenberg, Brian J, Sekine-Konno, Tomoko, Varma, Pradeep, Chen, Kewei, Koleske, Anthony J, Reiman, Eric M, Strittmatter, Stephen M, van Dyck, Christopher H
Publicado no Alzheimers Res Ther (2015)
“... at doses of 50 mg, 100 mg, 125 mg, or placebo daily for 4 weeks. The drug:placebo ratio was 3:1. Primary...”Publicado no Alzheimers Res Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Zhou, Tao, Zhang, Xia, Dong, Yan, Zhuang, Feifei, Jiang, Fengquan, Yu, Jinming, Zhang, Bin
Publicado no Drug Des Devel Ther (2016)
“... pain, theoretically without a dose cap. However, the dose is limited in clinical applications due...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
“...Hepatocellular and cholestatic forms of drug-induced liver injury (DILI) are major reasons for late...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Adams, Alyce S., Soumerai, Stephen B., Zhang, Fang, Gilden, Dan, Burns, Marguerite, Huskamp, Haiden, Trinacty, Connie, Alegria, Margarita, LeCates, Robert F., Griggs, Jennifer, Ross-Degnan, Dennis, Madden, Jeanne M.
Publicado no Clin Ther (2015)
“... adult dual enrollees with diabetes and comorbid depression living in states with strict drug caps (n=221...”Publicado no Clin Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por AlSaad, Doua, ElSalem, Samah, Abdulrouf, Palli Valapila, Thomas, Binny, Alsaad, Tayseer, Ahmed, Afif, AlHail, Moza
Publicado no Ther Clin Risk Manag (2016)
“... lactation inhibition to protect the health of mother and infant. Drug use evaluation (DUE) studies are done...”Publicado no Ther Clin Risk Manag (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Paulmurugan, Ramasamy, Bhethanabotla, Rohith, Mishra, Kaushik, Devulapally, Rammohan, Foygel, Kira, Sekar, Thillai V, Ananta, Jeyarama S, Massoud, Tarik F, Joy, Abraham
Publicado no Mol Cancer Ther (2015)
“... therapy. Off target effects and poor bioavailability of the FDA approved anti-obesity drug orlistat hinder...”Publicado no Mol Cancer Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Sugioka, Nobuyuki, Matsushita, Akiko, Kokuhu, Takatoshi, Bpharm, Okamoto, Masahiko, Yoshimura, Norio, Ito, Yukako, Shibata, Nobuhito, Takada, Kanji
Publicado em 2006
“...Background: In immunosuppressive therapy administered after organ transplantation, therapeutic drug...”Publicado em 2006
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo